Babesiosis is a human-animal parasitic disease caused by parasitic blood protozoa in erythrocytes of the genus Babesia, which are infected by tick vectors. Babesia can infect humans, rats, cattle, horses, sheep, dogs, deer, birds, and other animals. The clinical symptoms of human babesiosis are mainly characterized by intermittent fever, splenomegaly, jaundice and hemolysis. Babesiosis can cause serious harm to livestock production. In order to control the damage of Babesia, a lot of research work has been carried out worldwide.
CRISPR/Cas9 is a very effective genome-targeted modification system that enables precise gene editing such as gene knockout and knock-in, providing an innovative technology for gene function analysis, drug targeting and vaccine molecular screening of parasites. The CRISPR-Cas9 system has been applied to a variety of model organisms, including human, mouse, rat, Cryptobacterium hidradenum, plant and bacteria.
Ace Therapeutics, as a genome editing service provider, is focused on leveraging CRISPR/Cas9 technology and high-throughput screening to advance basic research and the pharmaceutical industry. We have a professional technical team and a perfect genome editing platform, and have been dedicated to providing customers with a full set of genome editing solutions such as sgRNA design and validation, vector construction, gene knockout, gene knock-in, gene targeted mutation and repair, off-target effect analysis and high-throughput sgRNA library screening for many years. We can provide CRISPR/Cas9 gene editing services for Babesia, laying the foundation for in-depth elucidation of mechanistic studies.
We have a technical team with rich experience in CRISPR gene editing, and we can currently realize services including gRNA design, CRISPR/Cas9 vector construction, cell transfection, positive clone identification, monoclonal cell culture, knockout cell line construction, etc. After the service is completed, we will deliver you the monoclonal cell line and detailed identification report. If you want to know more, you are welcome to consult us.
Customers need to provide
Delivery content: experiment report, gene editing monoclonal cell lines, or Babesia animal models that edited by CRISPR/Cas9 technology
Test fee: please get it through online inquiry.
Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.